Coding

Advocacy Update: Ringing in 2023

Author and Disclosure Information

We review the new digital pathology codes released on July 1, 2022, that will go into effect January 1, 2023. We also discuss the proposed physician fee schedule published by the Centers for Medicare & Medicaid Services in July 2022 that will negatively impact dermatology practices. Finally, we present the American Academy of Dermatology Association (AADA) advocacy priorities.

Practice Points

  • New digital pathology codes proposed by the American Medical Association can be used starting January 1, 2023.
  • A proposed 2023 fee schedule negatively impacting dermatology practices was published by the Centers for Medicare & Medicaid Services in July 2022.
  • Advocacy involvement provides a collaborative collective voice for our specialty to help our patients improve their care.


 

References

New Year, New Codes: A Win-Win for Digital Pathology

In July 2022, the American Medical Association CPT (Current Procedural Terminology) Editorial Panel released 13 new digital pathology add-on Category III codes for 2023 that the College of American Pathologists successfully advocated for inclusion.1 These codes are for reporting additional clinical staff work and service requirements associated with digitizing glass microscope slides for primary diagnosis (Table). They go into effect on January 1, 2023.

Digital Pathology

Although there is no additional compensation with the new Category III codes, dermatopathology laboratories will be able to report when they have made a diagnosis using digital pathology. The new CPT codes will provide payers with data they need to directly understand the utilization and increased value of digital pathology, which will bring dermatopathology laboratories one step closer to receiving additional reimbursement for digital interpretation.

The adoption of digital pathology has been accelerating in the United States but still lags behind many European countries where reimbursement for digital pathology has been established for many years. Many of the barriers to digital pathology have improved—cloud storage is more affordable, scanners have a higher throughput, digital pathology platforms have improved, and the US Food and Drug Administration has granted approvals for digital pathology. Digital pathology allows for more efficient workflow, which results in increased productivity and a reduction in turnaround times. It also allows for a wide spectrum of clinical applications and more innovation as well as research and educational applications.

The new Category III codes cannot be reported solely for archival purposes (eg, after the Category I service has already been performed and reported), solely for educational purposes (eg, when services are not used for individual patient reporting), solely for developing a database for training or validation of artificial intelligence algorithms, and solely for clinical conference presentations (eg, tumor board interdisciplinary conferences).

The new codes are a major victory for the adoption and future compensation for digital pathology.

New Year, New Cuts: Proposed 2023 Medicare Policy and Payment Changes for Dermatologists

The United States Spent $3.8 Trillion on Health Care in 2019: Where Did It Go?—In 2019, approximately $3.8 trillion was spent on health care in the United States (Figure 1). Physician services accounted for approximately 15% of total health care spending.2

The United States spent $3795.4 billion on health care in 2019

FIGURE 1. The United States spent $3795.4 billion on health care in 2019. Where did it all go? Data from the Centers for Medicare & Medicaid Services.2

Medicare Payments for Physician Services—Medicare payments for physician services are determined by a relative value unit (RVU) multiplied by a conversion factor (CF). Relative value units were set up in 1992 by what is now the Centers for Medicare & Medicaid Services, and they calculated the time it took a physician to complete a task or RVU and multiplied it by $32.00 (CF).3

Pages

Recommended Reading

Nurse practitioner fined $20k for advertising herself as ‘Doctor Sarah’
MDedge Dermatology
Skinny-label biosimilars provide substantial savings to Medicare
MDedge Dermatology
Don’t call me ‘Dr.,’ say some physicians – but most prefer the title
MDedge Dermatology
How to Foster Camaraderie in Dermatology Residency
MDedge Dermatology
U.S. biosimilar competition, use, and availability still lags behind European countries
MDedge Dermatology
Analysis of doctors’ EHR email finds infrequent but notable hostility
MDedge Dermatology
How blunt is too blunt for informed consent?
MDedge Dermatology
Women docs: How your next job contract can reflect your real goals
MDedge Dermatology
Florida doc dies by suicide after allegedly drugging and raping patients
MDedge Dermatology
Employers use patient assistance programs to offset their own costs
MDedge Dermatology